A missed dose is a fact
Everybody misses one. The question people actually ask at eleven at night, vial in hand, is not whether they have failed at something. It is what happens now.
There are two halves to that. What happens inside Claritide, which we can tell you exactly, because it is arithmetic we wrote. And what happens inside you, which depends on pharmacology most of our records do not publish. This lesson answers the first half completely and the second only as far as our sources go.
What Claritide does with a missed dose
Every scheduled dose is one row carrying one of four answers: taken, skipped, missed, or still waiting.
You answer it, or the clock does. Twelve hours after a dose was due, a row nobody has answered is recorded as missed. That happens the next time you open the app, since there is no server here to do it while you are away. That is the whole event. No alert, no red row, no streak to break. Coral in this app is reserved for safety flags, and a missed dose has never been one.
Nothing resets. A missed day is one day marked missed, and every day around it keeps what you logged. There is no score for it to pull down.
Doses taken counts it once. That figure is doses taken divided by doses taken, skipped and missed. Doses that have not come round yet are not in the denominator, so the number does not sag through the week and jump back on Monday.
A skip and a miss stay apart. Deciding not to take a dose and forgetting one are different events, and nothing in the app folds them together.
Days nobody was watching count as nothing. Claritide writes your schedule three weeks ahead and three days back each time you open it. If the app goes unopened long enough for that forward window to run out, the days in the middle were never written down, and they score neither for you nor against you. Time away is left out of the arithmetic rather than counted as rest.
Recording one, and what an honest reason buys you
Today carries a card listing missed and skipped doses from the last 30 days. Today's own doses are not on it, because a dose you can still log is not a closed fact yet.
Each row takes one optional tap: Travelled · Ran out · Side effect · Chose to skip · Forgot. The answer is stored with that dose, and it never overwrites a note you typed yourself.
It is worth the tap, and not for tidiness. A reason changes what a gap means when you read it back in eight weeks. Four blanks in one week is a decline if you do not know why and a work trip if you do. Ran out is a supply problem rather than an adherence one, and it can be routed like one. A side effect belongs in the safety record, where the physician report will find it. And chose to skip is frequently the correct call: ill, vial past its window, site not recovered. That is why it is recorded as a decision rather than a failure.
The one entry that does real damage is marking a dose taken that you did not take. It corrupts doses taken, the vial runway, every outcome comparison and the physician report at the same time. Nothing here punishes a blank, precisely so that nothing here tempts you to fill one in.
Whether the timing matters
Here the honest answer is mostly: our sources do not say.
Most records in this library publish no half-life at all, because no human figure was sourceable for them. Where that is true the record says so, and Claritide does not fill the gap: not from an animal study, not from a plausible guess. The Signal engine follows the same rule. Where a compound has a published half-life it compares your readings on days within two half-lives of a dose against days outside that window; where there is none, it compares dosing days only rather than inventing an active window to compare over.
Where a figure does exist it is on the compound's own page, and the spread is enormous. Our semaglutide record publishes a half-life of about one week, and the Ozempic label adds that the drug is still in the circulation about five weeks after a last dose. Our PT-141 record publishes about 2.7 hours. Pharmacology's rough convention is that after four to five half-lives a drug's plasma concentration falls below a clinically relevant level and is considered effectively eliminated. Those two compounds are not in the same situation the morning after a missed dose, and no single rule covers both.
One caution, because it is the mistake people make with this number. A half-life describes how fast a compound leaves the blood, not how long its effect lasts. The approved tesamorelin product's label reports an elimination half-life of eleven minutes, and it is a once-daily injection. What a peptide sets off can outlast the peptide by a wide margin, and for most of this library, nobody has measured either one.
Moving a dose
Claritide records the time you enter, not the time it planned. The logging screen prefills the scheduled time when you are catching up and the current time when you are early, and the field is editable in both cases. Enter the time you actually dosed.
That matters because two things read the clock rather than just the date.
- The food window compares each growth hormone secretagogue dose against your last food mark: clear at three hours or more, the edge between two and three, inside the window below two, and unassessable when the nearest mark is more than sixteen hours old. It reads the logged time.
- The hypothesis that splits your sleep scores by whether a dose landed clear of that window uses the same reading. A dose logged at its scheduled time when you actually injected three hours later can land on the wrong side of that split.
Day-level work, a dose change or a metric before and after, runs on calendar dates and never sees the hour, so an hour either way changes nothing there.
Some records publish a timing note of their own: DSIP's late-afternoon window, tesamorelin at bedtime on an empty stomach, PT-141's forty-five minutes ahead of time. Where a record publishes one, the record is where it is stated, with whatever reasoning our source gave for it. Most publish none.
The one decision this app will not make
Whether to make up a missed dose, take two, skip it, or move the schedule is a dose decision. It belongs to you and to whoever prescribes or supervises your protocol. Claritide does not make dose decisions, here or anywhere, however the question is put to it.
Where a compound in this library is an approved drug, its label may carry a missed-dose section of its own. Semaglutide's does, and it treats one missed dose differently from a run of them. That document, and the prescriber who wrote your prescription, is where that answer lives. Everything above is about what your record will look like afterwards.